Pharmafile Logo
Pharmafocus logo
Advanced Search

Celgene

Showing 15 posts of 128 posts found.

celgene_1_02_4

Celgene ‘stops Mylan entering market’

April 6, 2014
Sales and Marketing Celgene, Mylan, Revlimid, myeloma

Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …

News
rob_moore_celgene

New director named at Celgene

March 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, moore

Biopharma firm Celgene has appointed Rob Moore as its new Inflammation and Immunology business unit director. Moore has worked in …

Appointment
Celgene image

Celgene ‘downplayed’ Thalomid, Revlimid risks

February 7, 2014
Medical Communications, Sales and Marketing Celgene, Revlimid, Thalidomide, thalomid

A former sales representative for US pharma firm Celgene is accusing her old company of promoting two of its key …

News
Abraxane image

Cancer treatment Abraxane gets EU nod

January 9, 2014
Sales and Marketing Abraxane, Cancer, Celgene, EU, pancreatic

Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …

News
Celgene image

Celgene signs $177 million OncoMed deal

December 4, 2013
Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell

Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …

News
adrian_kilcoyne_celgene

Celgene hires new medical director

November 12, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne

Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …

Appointment
Celgene image

Celgene’s multiple myeloma pill launched in UK

August 15, 2013
Sales and Marketing Celgene, Velcade, low, myeloma

Celgene’s new oral blood cancer drug pomalidomide has been launched in the UK and Ireland as a third line treatment …

News
Celgene image

NICE no for Celgene’s Revlimid

July 11, 2013
Sales and Marketing Celgene, NICE, Revlimid

NICE has issued new draft guidance not recommending Celgene’s bone marrow disorder drug Revlimid over uncertainties of its efficacy. Revlimid …

News
Celgene image

Celgene predicts trio of blockbusters

June 5, 2013
Sales and Marketing Celgene, Pomalidomide, Revlamid, Velcade

Europe’s medicines committee the CHMP has just adopted a positive opinion for Celgene’s new multiple myeloma treatment Pomalidomide Celgene (pomalidomide). …

News

Celgene appoints new Haematology head

April 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, browne

Celgene has announced the appointment of Karen Browne as business unit director of Haematology, Celgene UK and Ireland. Over the …

Appointment
celgene_hugin

Big pharma appointments to PhRMA Board

April 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …

Appointment
sarah_bater

Celgene appoints new Human Resources director

January 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …

Appointment
Celgene image

Revlimid patient scheme ‘working’

December 14, 2012
Sales and Marketing Celgene, Revlimid

Celgene has issued figures which it says demonstrate the clinical value of the NICE-agreed patient access scheme for its cancer …

News
redfern_celgene

New director of market access at Celgene UK and Ireland

June 18, 2012
Business Services, Medical Communications, Sales and Marketing Celgene, Nicola Redfern, oncology

Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …

Appointment

Celgene appoints Thomas Moriarty as general counsel

May 9, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Moriarty

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025